Where disease pathogenesis meets protein formulation: Renal deposition of immunoglobulin aggregates
Authors:
- Robert GurnyRGRobert Gurny
- Tudor ArvinteTATudor Arvinte
- 1 February 2006
- journal article
- review article
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 62 (2) , 121-130
Abstract
No abstract availableKeywords
This publication has 82 references indexed in Scilit:
- Human Immunoglobulin Light Chains λ Form Amyloid Fibrils and Granular Aggregates in SolutionBiochemistry (Moscow), 2005
- Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseasesNature, 2002
- Both the environment and somatic mutations govern the aggregation pathway of pathogenic immunoglobulin light chain 1 1Edited by A. FershtJournal of Molecular Biology, 2001
- Mapping the Binding Domain of Immunoglobulin Light Chains for Tamm-Horsfall ProteinThe American Journal of Pathology, 2001
- Antibody humanization: a case of the ‘Emperor’s new clothes’?Immunology Today, 2000
- IgA aggregates stimulate monocyte chemotactic peptide‐1 expression in human mesangial cellsNephrology, 2000
- Study of the Relationship between Sticky Human Serum IgA1 and Its O-Glycan GlycoformBiochemical and Biophysical Research Communications, 1999
- Fragments of the Constant Region of Immunoglobulin Light Chains Are Constituents of AL-Amyloid ProteinsBiochemical and Biophysical Research Communications, 1998
- Extended Analysis of AL-Amyloid Protein from Abdominal Wall Subcutaneous Fat Biopsy: Kappa IV Immunoglobulin Light ChainBiochemical and Biophysical Research Communications, 1998
- Specificity of Abnormal Assembly in Immunoglobulin Light Chain Deposition Disease and AmyloidosisJournal of Molecular Biology, 1996